136 related articles for article (PubMed ID: 27928738)
1. Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study.
Jenkins H; Jenkins R; Patat A
Clin Drug Investig; 2017 Mar; 37(3):311-316. PubMed ID: 27928738
[TBL] [Abstract][Full Text] [Related]
2. The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations.
Echizen H
Clin Pharmacokinet; 2016 Apr; 55(4):409-18. PubMed ID: 26369775
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.
Sakurai Y; Shiino M; Okamoto H; Nishimura A; Nakamura K; Hasegawa S
Adv Ther; 2016 Sep; 33(9):1519-35. PubMed ID: 27432383
[TBL] [Abstract][Full Text] [Related]
4. Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects.
Hsyu PH; Pignataro DS; Matschke K
Eur J Clin Pharmacol; 2017 Jan; 73(1):49-56. PubMed ID: 27718000
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study.
Garonzik S; Byon W; Myers E; Li X; Marchisin D; Murthy B
Am J Cardiovasc Drugs; 2019 Dec; 19(6):561-567. PubMed ID: 31030414
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Drug-Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men.
Sakurai Y; Shiino M; Horii S; Okamoto H; Nakamura K; Nishimura A; Sakata Y
Clin Drug Investig; 2017 Jan; 37(1):39-49. PubMed ID: 27581248
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers.
Moore KH; Leese PT; McNeal S; Gray P; O'Quinn S; Bye C; Sale M
Clin Ther; 2002 Apr; 24(4):583-94. PubMed ID: 12017403
[TBL] [Abstract][Full Text] [Related]
8. Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters.
Gidal BE; Maganti R; Laurenza A; Yang H; Verbel DA; Schuck E; Ferry J
Epilepsy Res; 2017 Aug; 134():41-48. PubMed ID: 28535410
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not?
Szałek E; Karbownik A; Połom W; Matuszewski M; Sobańska K; Urjasz H; Grabowski T; Wolc A; Grześkowiak E
Pharmacol Rep; 2012; 64(6):1554-9. PubMed ID: 23406766
[TBL] [Abstract][Full Text] [Related]
10. Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials.
Dymond AW; So K; Martin P; Huang Y; Severin P; Mathews D; Lisbon E; Mariani G
Eur J Clin Pharmacol; 2017 Feb; 73(2):175-184. PubMed ID: 27889832
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytochrome P450 3A5 genotype on atorvastatin pharmacokinetics and its interaction with clarithromycin.
Shin J; Pauly DF; Pacanowski MA; Langaee T; Frye RF; Johnson JA
Pharmacotherapy; 2011 Oct; 31(10):942-50. PubMed ID: 21950641
[TBL] [Abstract][Full Text] [Related]
12. Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects.
Malhotra B; Dickins M; Alvey C; Jumadilova Z; Li X; Duczynski G; Gandelman K
Br J Clin Pharmacol; 2011 Aug; 72(2):263-9. PubMed ID: 21545485
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers.
Brophy DF; Israel DS; Pastor A; Gillotin C; Chittick GE; Symonds WT; Lou Y; Sadler BM; Polk RE
Antimicrob Agents Chemother; 2000 Apr; 44(4):978-84. PubMed ID: 10722500
[TBL] [Abstract][Full Text] [Related]
15. Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats.
Shen J; Wang B; Wang S; Chen F; Meng D; Jiang H; Zhou Y; Geng P; Zhou Q; Liu B
Drug Des Devel Ther; 2020; 14():2199-2206. PubMed ID: 32581516
[TBL] [Abstract][Full Text] [Related]
16. Effect of rifampin on the pharmacokinetics, safety and tolerability of navitoclax (ABT-263), a dual inhibitor of Bcl-2 and Bcl-XL , in patients with cancer.
Yang J; Pradhan RS; Rosen LS; Graham AM; Holen KD; Xiong H
J Clin Pharm Ther; 2014 Dec; 39(6):680-4. PubMed ID: 25047139
[TBL] [Abstract][Full Text] [Related]
17. Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers.
Markert C; Schweizer Y; Hellwig R; Wirsching T; Riedel KD; Burhenne J; Weiss J; Mikus G; Haefeli WE
Br J Clin Pharmacol; 2014 Jan; 77(1):141-8. PubMed ID: 23738582
[TBL] [Abstract][Full Text] [Related]
18. Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers.
Oh ES; Choi C; Kim CO; Kim KH; Kim YN; Kim SJ; Park MS
J Clin Pharm Ther; 2017 Dec; 42(6):689-694. PubMed ID: 28806472
[TBL] [Abstract][Full Text] [Related]
19. Effect of clarithromycin pre-treatment on the pharmacokinetics of metoclopramide after their simultaneous oral intake.
Kaukab I; Shah SNH; Kharaba ZJ; Buabeid MA; Alfoteih YA; Murtaza G
Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):735-740. PubMed ID: 32524862
[TBL] [Abstract][Full Text] [Related]
20. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
